SurePath™ Imaging Pap (REFL) HPV mRNA E6/E7 reflex HPV 16,18/45
Test Code
Clinical Significance
SurePath™ Imaging Pap (REFL) HPV mRNA E6/E7 reflex HPV 16,18/45 - Liquid based Pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the Bethesda System for Reporting Results of Cervical Cytology. Pap screening is not reliable for the detection of endometrial cancer.
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Pap results requiring physician interpretation will be performed at an additional charge (CPT code(s): 88141; HCPCS: G0124).
For interpretations of Atypical Squamous Cells (ASC), HPV mRNA E6/E7 will be performed at an additional charge (CPT code(s): 87624).
Methodology
Reference Range(s)
Preferred Specimen(s)
Pap sample collected with a cytobroom or cytobrush and spatula. Cytobroom tip submitted in a SurePath™ vial. Alcohol based solution that serves as preservative and transport media for gynecological samples.
Minimum Volume
1 SurePath™ vial
Transport Container
SurePath™ vial
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: Unacceptable
Reject Criteria
Unlabeled vial • Leakage of fluid during transport • Mismatch between name of patient on vial and name on test requisition • SurePath™ (blue) vials without the head of the collection device(s) in the fluid • Expired vial
Setup Schedule
Refrigerated: 7 days
Frozen: Unacceptable